{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:55:36Z","timestamp":1785524136421,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405512"],"award-info":[{"award-number":["82405512"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82575169"],"award-info":[{"award-number":["82575169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01997-8","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:40:13Z","timestamp":1785303613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dihydrolipoamide dehydrogenase promotes hepatocellular carcinoma progression and modulates cuproptosis-dependent cell death"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1938-6882","authenticated-orcid":false,"given":"Mao-feng","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2963-0559","authenticated-orcid":false,"given":"Yu-yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3773-8131","authenticated-orcid":false,"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3792-8833","authenticated-orcid":false,"given":"Tian-xiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9562-3238","authenticated-orcid":false,"given":"Lu-yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-3992","authenticated-orcid":false,"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-3392","authenticated-orcid":false,"given":"Wan-fu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"1997_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41420-025-02734-z","volume":"11","author":"S Abraham Gnanadass","year":"2025","unstructured":"Abraham Gnanadass S, Pandey S, Viswanathan P (2025) Decoding cuproptosis and cuproplasia: implications for therapeutic strategies in renal cell carcinoma. Cell Death Discov 11:501. https:\/\/doi.org\/10.1038\/s41420-025-02734-z","journal-title":"Cell Death Discov"},{"key":"1997_CR2","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.1111\/tra.70024","volume":"26","author":"V Anjana","year":"2025","unstructured":"Anjana V, Anand S, Thakur P, Pal R, Acharjee S, Singh R, Sharma S, Kumawat M, Tomar RS (2025) Copper Homeostasis at the Crossroads of Cellular Metabolism, Epigenetic Regulation and Protein Trafficking. Traffic 26:e70024. https:\/\/doi.org\/10.1111\/tra.70024","journal-title":"Traffic"},{"key":"1997_CR3","doi-asserted-by":"publisher","first-page":"118422","DOI":"10.1016\/j.biopha.2025.118422","volume":"190","author":"DL Boaru","year":"2025","unstructured":"Boaru DL, Leon-Oliva D, Castro-Martinez P, Garcia-Montero C, Fraile-Martinez O, Garcia-Gonzalez B, Perez-Gonzalez I, Michael Alhaddadin MN, Barrena-Blazquez S, Lopez-Gonzalez L, la Torre B, Guijarro LG, Pekarek L, Saez MA, Rios-Espinosa L, Garrido-Gil MJ, Gimeno-Longas MJ, Pekarek T, Diaz-Pedrero R, Alvarez-Mon M, Ortega MA (2025) Cuproptosis: Current insights into its multifaceted role in disease, cancer, and translational\/therapeutic opportunities. Biomed Pharmacother 190:118422. https:\/\/doi.org\/10.1016\/j.biopha.2025.118422","journal-title":"Biomed Pharmacother"},{"key":"1997_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.actbio.2025.11.028","volume":"209","author":"PP Cui","year":"2026","unstructured":"Cui PP, Yang QC, Sun ZJ (2026) Targeting cuproptosis with nanomaterials for cancer immunotherapy. Acta Biomater 209:38\u201363. https:\/\/doi.org\/10.1016\/j.actbio.2025.11.028","journal-title":"Acta Biomater"},{"key":"1997_CR5","doi-asserted-by":"publisher","first-page":"e70224","DOI":"10.1111\/jcmm.70224","volume":"28","author":"K Guo","year":"2024","unstructured":"Guo K, Wang T, Yin J, Yang S, Cui H, Cao Z, Zhao Q, Xie G, Lu J, Gu G, Wu W (2024) Identification of Cuproptosis-Related Patterns Predict Prognosis and Immunotherapy Response in Hepatocellular Carcinoma. J Cell Mol Med 28:e70224. https:\/\/doi.org\/10.1111\/jcmm.70224","journal-title":"J Cell Mol Med"},{"key":"1997_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67869-0","author":"JC Hsiao","year":"2025","unstructured":"Hsiao JC, Warui DM, Kwon JJ, Dreishpoon MB, Bick NR, Blue-Lahom T, Root DE, Booker SJ, Tsvetkov P (2025) Deep Mutational Scanning of FDX1 Identifies Key Structural Determinants of Lipoylation and Cuproptosis. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-025-67869-0","journal-title":"Nat Commun"},{"key":"1997_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.12.002","author":"D Jiang","year":"2025","unstructured":"Jiang D, Zhuang L, Koong AC, Gan B (2025a) Cuproptosis in cancer: from molecular mechanisms to therapeutic intervention. Trends Cancer DOI. https:\/\/doi.org\/10.1016\/j.trecan.2025.12.002","journal-title":"Trends Cancer DOI"},{"key":"1997_CR8","doi-asserted-by":"publisher","unstructured":"Jiang Z, Dai J, Jiang J, Deng S, Gu J, Wang J, Chen M, Cai W, Wu K, Tao K, Liu K, Cai K (2025b) Engineering Inorganic Nanoparticles to Induce Cuproptosis: A New Strategy for Cancer Therapy. Pharmaceutics 17. https:\/\/doi.org\/10.3390\/pharmaceutics17111383","DOI":"10.3390\/pharmaceutics17111383"},{"key":"1997_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-022-01014-x","volume":"7","author":"SR Li","year":"2022","unstructured":"Li SR, Bu LL, Cai L (2022) Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduct Target Ther 7:158. https:\/\/doi.org\/10.1038\/s41392-022-01014-x","journal-title":"Signal Transduct Target Ther"},{"key":"1997_CR10","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.21037\/tcr-24-350","volume":"13","author":"X Li","year":"2024","unstructured":"Li X, Li L, He N, Kou D, Chen S, Song H, Yan X (2024a) Pathomics signatures and cuproptosis-related genes signatures for prediction of prognosis in patients with hepatocellular carcinoma. Transl Cancer Res 13:5473\u20135483. https:\/\/doi.org\/10.21037\/tcr-24-350","journal-title":"Transl Cancer Res"},{"key":"1997_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2174\/0115680096271679231213060750","volume":"24","author":"X Li","year":"2024","unstructured":"Li X, Rui J, Yang Z, Shang-Guan F, Shi H, Wang D, Sun J (2024b) Cuproptosis Related Gene DLD Associated with Poor Prognosis and Malignant Biological Characteristics in Lung Adenocarcinoma. Curr Cancer Drug Targets 24:867\u2013880. https:\/\/doi.org\/10.2174\/0115680096271679231213060750","journal-title":"Curr Cancer Drug Targets"},{"key":"1997_CR12","doi-asserted-by":"publisher","first-page":"5533444","DOI":"10.1155\/2023\/5533444","volume":"2023","author":"J Lin","year":"2023","unstructured":"Lin J, Wang G, Cheng S, Hu Y, Li H, Feng W, Liu X, Xu C (2023) Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD. Mediators Inflamm 2023:5533444. https:\/\/doi.org\/10.1155\/2023\/5533444","journal-title":"Mediators Inflamm"},{"key":"1997_CR13","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.7150\/jca.96867","volume":"15","author":"K Lin","year":"2024","unstructured":"Lin K, Cai J, Pan S, Yu X, Qiu Y, Ying Z, Feng H, Zhang L, Liu Y, Shen H, Hong Y, Li Q, Jin R (2024) Screening of PDSS1 as a Potential Biomarker for Hepatocellular Carcinoma Based on a Copper-Related Prognostic Signature through Bulk and Single-cell RNA-sequencing Analysis. J Cancer 15:5028\u20135045. https:\/\/doi.org\/10.7150\/jca.96867","journal-title":"J Cancer"},{"key":"1997_CR15","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H (2022) Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res 12:4074\u20134081","journal-title":"Am J Cancer Res"},{"key":"1997_CR14","doi-asserted-by":"publisher","first-page":"e18091","DOI":"10.1111\/jcmm.18091","volume":"28","author":"C Liu","year":"2024","unstructured":"Liu C, Fang Z, Yang K, Ji Y, Yu X, Guo Z, Dong Z, Zhu T, Liu C (2024) Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease. J Cell Mol Med 28:e18091. https:\/\/doi.org\/10.1111\/jcmm.18091","journal-title":"J Cell Mol Med"},{"key":"1997_CR16","doi-asserted-by":"publisher","first-page":"1584811","DOI":"10.3389\/fonc.2025.1584811","volume":"15","author":"X Liu","year":"2025","unstructured":"Liu X, Qu H, Li J, Sun X, Wang Z, Wang D, Bai X, Li X (2025) p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation. Front Oncol 15:1584811. https:\/\/doi.org\/10.3389\/fonc.2025.1584811","journal-title":"Front Oncol"},{"key":"1997_CR17","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","volume":"52","author":"M Nagai","year":"2012","unstructured":"Nagai M, Vo NH, Shin Ogawa L, Chimmanamada D, Inoue T, Chu J, Beaudette-Zlatanova BC, Lu R, Blackman RK, Barsoum J, Koya K, Wada Y (2012) The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic Biol Med 52:2142\u20132150. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.03.017","journal-title":"Free Radic Biol Med"},{"key":"1997_CR18","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1038\/s41467-021-25570-y","volume":"12","author":"J Skerlova","year":"2021","unstructured":"Skerlova J, Berndtsson J, Nolte H, Ott M, Stenmark P (2021) Structure of the native pyruvate dehydrogenase complex reveals the mechanism of substrate insertion. Nat Commun 12:5277. https:\/\/doi.org\/10.1038\/s41467-021-25570-y","journal-title":"Nat Commun"},{"key":"1997_CR19","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","volume":"293","author":"A Solmonson","year":"2018","unstructured":"Solmonson A, DeBerardinis RJ (2018) Lipoic acid metabolism and mitochondrial redox regulation. J Biol Chem 293:7522\u20137530. https:\/\/doi.org\/10.1074\/jbc.TM117.000259","journal-title":"J Biol Chem"},{"key":"1997_CR20","doi-asserted-by":"publisher","first-page":"111879","DOI":"10.1016\/j.cbi.2025.111879","volume":"424","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhou M, Lan J, Hu T, Wang T, Zuo C (2025) Copper homeostasis and its dysregulation in diseases: A focus on cuproptosis. Chem Biol Interact 424:111879. https:\/\/doi.org\/10.1016\/j.cbi.2025.111879","journal-title":"Chem Biol Interact"},{"key":"1997_CR21","doi-asserted-by":"publisher","first-page":"9245667","DOI":"10.1155\/2023\/9245667","volume":"2023","author":"C Wu","year":"2023","unstructured":"Wu C, Liu X, Zhong L, Zhou Y, Long L, Yi T, Chen S, Li Y, Chen Y, Shen L, Zeng Q, Tang S (2023) Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease. Oxid Med Cell Longev 2023:9245667. https:\/\/doi.org\/10.1155\/2023\/9245667","journal-title":"Oxid Med Cell Longev"},{"key":"1997_CR22","doi-asserted-by":"publisher","first-page":"126267","DOI":"10.1016\/j.ijpharm.2025.126267","volume":"685","author":"T Wu","year":"2025","unstructured":"Wu T, Wang S, Liu Y, Bai X, Shi C (2025) Roles and mechanisms of cuproptosis for reversing cancer therapeutic resistance. Int J Pharm 685:126267. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126267","journal-title":"Int J Pharm"},{"key":"1997_CR23","doi-asserted-by":"publisher","first-page":"104255","DOI":"10.12998\/wjcc.v13.i24.104255","volume":"13","author":"J Xiao","year":"2025","unstructured":"Xiao J, Wang Y, Yang XJ (2025) Mechanism of action of cuproptosis and prospects for anti-tumor therapy. World J Clin Cases 13:104255. https:\/\/doi.org\/10.12998\/wjcc.v13.i24.104255","journal-title":"World J Clin Cases"},{"key":"1997_CR25","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1007\/s00432-023-05099-x","volume":"149","author":"S Xu","year":"2023","unstructured":"Xu S, Dong K, Gao R, Yang Y, Zhou Y, Luo C, Chen W, Liu SM (2023) Cuproptosis-related signature for clinical prognosis and immunotherapy sensitivity in hepatocellular carcinoma. J Cancer Res Clin Oncol 149:12249\u201312263. https:\/\/doi.org\/10.1007\/s00432-023-05099-x","journal-title":"J Cancer Res Clin Oncol"},{"key":"1997_CR24","doi-asserted-by":"publisher","first-page":"112236","DOI":"10.1016\/j.cellsig.2025.112236","volume":"138","author":"M Xu","year":"2026","unstructured":"Xu M, An Y, Liu X, Li X, Huang X, Gu Q, Xue M, Xue J, Tao L, Shan H, Chen X, Zhang M (2026) The molecular mechanisms of cuproptosis and its role in central nervous system diseases. Cell Signal 138:112236. https:\/\/doi.org\/10.1016\/j.cellsig.2025.112236","journal-title":"Cell Signal"},{"key":"1997_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/10445498251403436","author":"Q Yang","year":"2025","unstructured":"Yang Q, Zhao Y, Zhu L, Xu X, Deng H, Tong H, Chen K (2025) Cuproptosis: Revolutionizing Cancer Treatment with Copper\u2019s Hidden Potential. DNA Cell Biol DOI. https:\/\/doi.org\/10.1177\/10445498251403436","journal-title":"DNA Cell Biol DOI"},{"key":"1997_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ijrobp.2020.12.062","volume":"110","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Cao W, Zhou H, Qian H, Wang H (2021) CLTRN, Regulated by NRF1\/RAN\/DLD Protein Complex, Enhances Radiation Sensitivity of Hepatocellular Carcinoma Cells Through Ferroptosis Pathway. Int J Radiat Oncol Biol Phys 110:859\u2013871. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.062","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1997_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12935-025-03683-4","volume":"25","author":"R Zhang","year":"2025","unstructured":"Zhang R, Tan Y, Xu K, Huang N, Wang J, Liu M, Wang L (2025a) Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment. Cancer Cell Int 25:137. https:\/\/doi.org\/10.1186\/s12935-025-03683-4","journal-title":"Cancer Cell Int"},{"key":"1997_CR30","doi-asserted-by":"publisher","unstructured":"Zhang SY, Ren XH, Zhang CH, Wang ZY (2025b) NADH-Reductive Stress Induced by Dihydrolipoamide Dehydrogenase Activation Contributes to Cuproptosis. Adv Sci (Weinh) e20444. https:\/\/doi.org\/10.1002\/advs.202520444","DOI":"10.1002\/advs.202520444"},{"key":"1997_CR28","doi-asserted-by":"publisher","unstructured":"Zhang L, Cheng Y, Tang L, Zhu J, Tuo B (2026) Role of cuproptosis in digestive system tumors (Review). Int J Mol Med 57. https:\/\/doi.org\/10.3892\/ijmm.2026.5727","DOI":"10.3892\/ijmm.2026.5727"},{"key":"1997_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12964-024-01743-2","volume":"22","author":"R Zhao","year":"2024","unstructured":"Zhao R, Sukocheva O, Tse E, Neganova M, Aleksandrova Y, Zheng Y, Gu H, Zhao D, Madhunapantula SV, Zhu X, Liu J, Fan R (2024) Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy? Cell Commun Signal 22:379. https:\/\/doi.org\/10.1186\/s12964-024-01743-2","journal-title":"Cell Commun Signal"},{"key":"1997_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q, Jin H (2025) Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther 10:35. https:\/\/doi.org\/10.1038\/s41392-024-02075-w","journal-title":"Signal Transduct Target Ther"},{"key":"1997_CR33","doi-asserted-by":"publisher","first-page":"1557223","DOI":"10.3389\/fimmu.2025.1557223","volume":"16","author":"H Zhu","year":"2025","unstructured":"Zhu H, Zhao Y, Wang Y, Wei G, Liu J (2025) Understanding the relationship between cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies. Front Immunol 16:1557223. https:\/\/doi.org\/10.3389\/fimmu.2025.1557223","journal-title":"Front Immunol"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01997-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:32:42Z","timestamp":1785519162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01997-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01997-8","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"209"}}